《速度与激情：为 COVID-19 恢复期血浆寻找临床定位》。
The Fast and the Furious: Chasing a Clinical Niche for COVID-19 Convalescent Plasma.
机构信息
Hennepin Healthcare and Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
出版信息
Ann Intern Med. 2022 Sep;175(9):1332-1334. doi: 10.7326/M22-2329. Epub 2022 Aug 16.
The Association for the Advancement of Blood and Biotherapies reported a thorough analysis of existing data and guidelines for the use of COVID-19 convalescent plasma (CCP) for treatment and prophylaxis of COVID-19. The editorialists discuss the recommendations, how they compare with recommendations from other entities, and the lessons the experience with CCP provides for the use of passive immunotherapy for future emerging infectious diseases.
血液和生物疗法促进协会报告了对现有数据和 COVID-19 恢复期血浆（CCP）用于 COVID-19 治疗和预防的使用指南的全面分析。社论作者讨论了这些建议，以及它们与其他实体的建议相比如何，以及 CCP 经验为未来新发传染病的被动免疫治疗提供了哪些教训。
Zotero 插件